Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07789119
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Biospecimens
  • Molecular Analysis
  • Prospective Collection
  • Urinary Tract
  • Urothelial Carcinoma (UC)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • biospecimen Collection — DIAGNOSTIC_TEST
    biospecimen collection during routine care encounters or clinically indicated procedures

Study Details

To collect, process, store, and study biological samples and related clinical and imaging data from participants with known or suspected urothelial carcinoma or another related malignancy of the urinary tract.

Key Dates

First listed
Aug 27, 2026
Start date
Feb 6, 2027
Status verified
Aug 2026
Primary completion
Dec 31, 2036
Completion
Dec 31, 2038

Study Design

Enrollment
50,000 participants (estimated)

Primary Outcome Measure

Overall Survival [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD Anderson Cancer CenterHoustonTexas77030
Bryon Lee, MD
[email protected]
713-792-3250
Byron Lee, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
UT MD Anderson Cancer Center· Houston, TX

Related Studies